MAP2K7 and Alzheimer disease: Taken together, all the aforementioned results indicate that EZH2 may play a critical role during VSMC loss or even AD occurrence via regulating autophagy, which is largely mediated by regulating ATG5 and ATG7 expression and the MEK–ERK1/2 signaling pathway (Fig. 7).